RMD - Resmed
This page shows which of the focused investors we track hold RMD and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2023 it was held by 2 managers with an aggregate reported value of $5.85M, which is 0.00% of the combined portfolio.
As of Q2 2023, 2 tracked institutional managers held RMD (Resmed) with an aggregate reported value of $5.85M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades RMD — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2023
- Ticker
- RMD
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Jensen Investment Management - Jensen Investment Management | 0.04% | Add +17.5% | 23,090 | $5.05M |
| 2 | Lee Ainslie - Maverick Capital | 0.02% | Add +159.3% | 3,706 | $809.76K |
Loading holder history for RMD…